Clobetasol Propionate Ointment USP, 0.05%

FDA Drug Profile — Clobetasol Propionate

Clobetasol Propionate Ointment USP, 0.05% is listed in the FDA National Drug Code directory with 19 NDC codes, marketed under brand name including Clobetasol Propionate. Available dosage form: ointment.

Drug details

Generic Name
Clobetasol Propionate Ointment USP, 0.05%
Brand Names
Clobetasol Propionate
Application Number
ANDA211295
Sponsor
Encube Ethicals, Inc.
NDC Codes
19
Dosage Forms
OINTMENT
Routes
TOPICAL
Active Ingredients
CLOBETASOL PROPIONATE

Indications and Usage

INDICATIONS AND USAGE Clobetasol propionate ointment USP, 0.05% is super-high potency corticosteroid formulations indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 g/week because of the potential for the drug to suppress the hypothalamic-pituitary- adrenal (HPA) axis. Use in pediatric patients under 12 years of age is not recommended. As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.